ZytoNova

WIPO WIPO 2022

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke ZytoNova wurde als Wortmarke am 17.11.2022 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 10. August 2023

Markenform Wortmarke
Aktenzeichen 1725888
Länder Australien China Großbritannien Indien Südkorea Norwegen Türkei Vereinigte Staaten von Amerika (USA)
Basismarke EU Nr. 018610297, 29. November 2021
Anmeldedatum 17. November 2022
Ablaufdatum 17. November 2032

Markeninhaber

Fischkai 1
27572 Bremerhaven
DE

Markenvertreter

Waren und Dienstleistungen

01 Chemicals for use in industry and science; chemicals, biochemicals, for use in the following fields: pathology, genetics, human genetics, molecular pathologies, molecular biology, microbiology, biotechnology, laboratory medicine; chemicals and biochemicals for histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, pcr (polymerase chain reaction), ngs (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry services and isolation of biomolecules including dna, rna and proteins; nucleic acids (including dna, rna, oligonucleotides, polynucleotides, marked nucleic acids and modified nucleic acids), proteins (including peptides, recombinant proteins and marked proteins), antibodies, dna probes being biochemical substances, rna probes being biochemical substances, oligonucleotide probes being biochemical substances, cells, tissue, tissue sections, and nucleic acids, proteins and cells immobilised on carriers
05 Pharmaceuticals and medical preparations; medical preparations for diagnostics; medical preparations for in-vitro diagnostics; pharmaceuticals, pharmaceutical preparations, medical products, medical preparations, chemical products, chemical preparations, biochemical products, biochemical preparations for medical use; pharmaceutical, medicated, chemical and biochemicals and preparations for medical purposes for histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, pcr (polymerase chain reaction), ngs (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry services and isolation of biomolecules including dna, rna and proteins; nucleic acids (including dna, rna, oligonucleotides, polynucleotides, marked nucleic acids and modified nucleic acids), proteins (including peptides, recombinant proteins and marked proteins), antibodies, dna probes being biochemical substances, rna probes being biochemical substances, oligonucleotide probes being biochemical substances, cells, tissue, tissue sections, and nucleic acids, proteins and cells immobilised on carriers
09 Scientific research and laboratory apparatus, educational apparatus and simulators; analysis apparatus for conducting and evaluating histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, pcr (polymerase chain reaction), ngs (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry and isolation of biomolecules including dna, rna and proteins; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids, analysis apparatus for research laboratories for measuring, testing and examining tissue, cells and biomolecules including dna, rna and proteins
10 Medical apparatus and instruments; medical instruments; medical analytical apparatus for medical purposes; automatic analyzers for medical diagnosis; physical analyzers for medical use; genetic testing apparatus for medical purposes
35 Business management consultancy and advisory services; operation of businesses [for others]; running of a holding company, namely business management, business administration, office functions; holding company services, namely marketing strategy, professional business and organisational consultancy and management of the business interests of others and legally independent companies; business management and organization consultancy; advisory services for business management; business administration; office functions; planning and monitoring of business developments with regard to organisational matters
42 Scientific and technology services; medical laboratory services; medical research laboratory services; development of pharmaceutical preparations and medicines; clinical research; research relating to biotechnology; scientific consultancy services; biological analysis, biochemical analysis, chemical analysis, scientific analysis; scientific research in the field of genetics and genetic engineering
44 Medical services; medical diagnostic services; in vitro analysis for medical and pharmaceutical use; medical services using the knowledge in the field of pathology, genetic science, human genetics, molecular pathologies, molecular biology, microbiology, biotechnology and laboratory medicine; medical services by means of histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, pcr (polymerase chain reaction), ngs (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry and isolation of biomolecules including dna, rna and proteins; medical counseling; pharmaceutical services; pharmaceutical advice; medical and health services relating to dna, genetics and genetic testing; pathology services; genetic testing for medical purposes
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
07. August 2023 2023/32 Gaz CN Ablehnung
12. Juli 2023 2023/28 Gaz GB Ablehnung
17. November 2022 2023/14 Gaz EM Eintragung

ID: 141725888